Bioequivalence Study of Oseltamivir Phosphate and TAMIFLU Under Fed Condition in Healthy Volunteers
Phase 4
Completed
- Conditions
- Bioequivalence
- Interventions
- First Posted Date
- 2020-09-02
- Last Posted Date
- 2023-02-02
- Lead Sponsor
- Austarpharma, LLC
- Target Recruit Count
- 96
- Registration Number
- NCT04536415
- Locations
- 🇺🇸
Austarpharma Llc, Edison, New Jersey, United States
© Copyright 2025. All Rights Reserved by MedPath